Shikar Bipin Dharamsey Nensey

Shikar Bipin Dharamsey Nensey

Active Director Nominee Director DIN 06561383
DIN 06561383 First appointment May 2013 Primary industry Financial Services
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 1 historical roles
Total affiliations 3 Since May 2013
Shareholding value •••• Premium profile

About Shikar Bipin Dharamsey Nensey

Data last updated:

Shikar Bipin Dharamsey Nensey is a Nominee Director at Multi-Act Trade And Investments Private Limited (since 2013) and Director at Midcap Construction Enterprises Private Limited (since 2019). The companies operate in Financial Services, Real Estate and Construction and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹39.30 Cr; the largest is Multi-Act Trade And Investments Private Limited at ₹38.73 Cr (FY 2025). Earlier, Shikar Bipin Dharamsey Nensey was a Director at Cytecare Hospitals Private Limited (2015–2025).

DIN 06561383
Primary Designation Nominee Director
Industry Financial Services
First Appointment 14 May 2013
Oldest Company Age 36 yrs
Largest company Multi-Act Trade And Investments Private Limited · ₹38.73 Cr (FY 2025)
Combined revenue ₹39.30 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nominee Director14 May 20131997₹38.73 Cr (FY 2025)Active
Director29 Nov 20191990₹57.6 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cytecare Hospitals Private Limited U85110GJ2014PTC079078
Director15 Sep 20152014₹93.10 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Multi-Act Trade And Investments Private Limited
Midcap Construction Enterprises Private Limited
Cytecare Hospitals Private Limited
Premium access

Shareholding and investment profile for Shikar Bipin Dharamsey Nensey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shikar Bipin Dharamsey Nensey

Shikar Bipin Dharamsey Nensey currently holds 2 directorships: Multi-Act Trade And Investments Private Limited (Nominee Director, since 14 May 2013, revenue ₹38.73 Cr (FY 2025)); Midcap Construction Enterprises Private Limited (Director, since 29 Nov 2019, revenue ₹57.6 Lakh (FY 2025)).

Shikar Bipin Dharamsey Nensey was first appointed on 14 May 2013 as Nominee Director at Multi-Act Trade And Investments Private Limited. The most recent appointment on record is 29 Nov 2019 at Midcap Construction Enterprises Private Limited.

The 2 current companies of Shikar Bipin Dharamsey Nensey that report revenue have a combined latest revenue of ₹39.30 Cr: Multi-Act Trade And Investments Private Limited ₹38.73 Cr (FY 2025); Midcap Construction Enterprises Private Limited ₹57.6 Lakh (FY 2025).

Shikar Bipin Dharamsey Nensey held 1 earlier board appointment: Cytecare Hospitals Private Limited (Director, 15 Sep 2015 to 03 Nov 2025).

The current boards of Shikar Bipin Dharamsey Nensey's companies include Ashutosh Bishnoi (Multi-Act Trade And Investments Private Limited), Dattaraj Vassudeva Salgaocar (Multi-Act Trade And Investments Private Limited), Deep Shah (Multi-Act Trade And Investments Private Limited), Mehul Trivedi Kunjbihari (Multi-Act Trade And Investments Private Limited), Prashant Kunjbihari Trivedi (Multi-Act Trade And Investments Private Limited), Rajendra Kalur (Multi-Act Trade And Investments Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available